ArticleAnnals of hematology2023

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study.

M Macro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.